Change in serum sodium level predicts clinical manifestations of transurethral resection syndrome: a retrospective review

Table 2 Baseline demographic and clinical characteristics of patients that underwent transurethral resection of the prostate

Parameter	Symptomatic (n = 60)	Asymptomatic (n = 169)	Pvalue
Age, yr	72 ± 8	70 ± 7	0.146
Height, cm	164.6 ± 6.2	164.8 ± 6.0	0.788
Body weight, kg	62.9 ± 10.0	63.2 ± 9.5	0.862
Diabetes mellitus	4 (66.7%)	11 (6.5%)	1.000
Hypertension	6 (10.0%)	14 (8.3%)	0.395
Arrhythmia	1 (1.7%)	1 (0.6%)	0.456
Preoperative blood data
Creatinine, mg/dl	0.9 ± 0.2	0.9 ± 0.2	0.861
BUN, mg/dl	16.6 ± 6.1	15.7 ± 4.1	0.619
Sodium, mmol/l	140.8 ± 2.1	140.7 ± 2.3	0.963
Hemoglobin, g/dl	13.6 ± 1.5	14.0 ± 1.5	0.078
Estimated prostatic grand size, g	87.8 ± 41.8	64.9 ± 26.6	<0.001

Data expressed as mean ± SD or number (%). Transurethral resection syndrome was defined as the presence of central nervous system disturbances such as nausea, vomiting, restlessness, pain, confusion, or even coma with circulatory abnormalities both intra- and post-operatively.
Asymptomatic, patients with no signs of transurethral resection syndrome; Symptomatic, patients with signs of transurethral resection syndrome; BUN, blood urea nitrogen.

ISSN: 1471-2253